{"id":"W2604892075","doi":"10.1182/blood.v128.22.1841.1841","title":"ZW38, a Novel Azymetric Bispecific CD19-Directed CD3 T Cell Engager Antibody Drug Conjugate with Controlled T Cell Activation and Improved B Cell Cytotoxicity","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"ca_institutions":"Zymeworks (Canada)","funders":"","keywords":"Blinatumomab; CD19; Antibody; T cell; Antibody-drug conjugate; Cancer research; B cell; Immunology; Medicine; Molecular biology; Chemistry; Biology; Immune system; Monoclonal antibody","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001114303,0.0004622961,0.0001625901,0.0002053003,0.00008680596,0.000190551,0.0003489205,0.000345136,0.002977641],"category_scores_gemma":[0.000122757,0.0001328221,0.0001576422,0.0001414664,0.0001279746,0.0003751222,0.0003158278,0.0004083437,0.0007783666],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000356466,"about_ca_system_score_gemma":0.000191179,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005419584,"about_ca_topic_score_gemma":0.0005084513,"domain_scores_codex":[0.9999155,0.00001264725,0.000005579957,0.00001815567,0.00002798197,0.00002010403],"domain_scores_gemma":[0.9999688,0.000002286666,0.00001135464,0.000002339489,0.00000600182,0.000009262439],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.000365447,0.000110817,0.0001442792,0.0001681755,0.00001591777,0.0002037615,0.00002623954,0.0009132356,0.9677605,0.0007845777,0.001225863,0.02828117],"study_design_scores_gemma":[0.0002015847,0.002291792,0.0007103753,0.00001193434,0.00003092291,0.001220433,0.00001157307,0.003445646,0.9682403,0.0001816999,0.02363837,0.00001548506],"study_design_candidate":"bench_or_experimental","study_design_consensus":"bench_or_experimental","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9535295,0.00907047,0.01633885,0.0007391878,0.0001572914,0.0003595419,0.0008490362,0.0005899094,0.01836617],"genre_scores_gemma":[0.9816026,0.00196075,0.007491176,0.0002036552,0.00002146848,0.000100175,0.0005415297,0.00003147459,0.008047228],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002977641,"threshold_uncertainty_score":0.009961188,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01371884965326666,"score_gpt":0.2543328361908271,"score_spread":0.2406139865375604,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}